Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Wardelmann

Showing results (221-230 of 248) with videos related to

Pageof 25
Sort By:
British Journal of Cancer|January 21, 2022
The association of Health-Related Quality of Life and 1-year-survival in sarcoma patients-results of a Nationwide Observational Study (PROSa)Martin Eichler, Susanne Singer, Leopold Hentschel, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2025
Conference on challenges in sarcoma (CCS) 2024: Expert opinions on non-evidence-based management aspectsSilvia Hofer, Chantal Pauli, Beata Bode, et al.
Nature Communications|August 4, 2019
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AMLThomas Oellerich, Constanze Schneider, Dominique Thomas, et al.
The American Journal of Pathology|January 26, 2021
Gene Expression in Solitary Fibrous Tumors (SFTs) Correlates with Anatomic Localization and NAB2-STAT6 Gene Fusion VariantsMatthias Bieg, Evgeny A Moskalev, Rainer Will, et al.
Genes, Chromosomes & Cancer|October 26, 2019
Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assaysNicole Pfarr, Martina Kirchner, Ulrich Lehmann, et al.
JAMA|March 29, 2012
One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trialHeikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, et al.
Frontiers in Endocrinology|September 15, 2023
Health related Quality of Life over time in German sarcoma patients. An analysis of associated factors - results of the PROSa studyMartin Eichler, Leopold Hentschel, Susanne Singer, et al.
Clinical Orthopaedics and Related Research|October 4, 2019
Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 TrialDimosthenis Andreou, Andreas Ranft, Georg Gosheger, et al.
Cancers|December 3, 2020
The Health-Related Quality of Life of Sarcoma Patients and Survivors in Germany-Cross-Sectional Results of a Nationwide Observational Study (PROSa)Martin Eichler, Leopold Hentschel, Stephan Richter, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 25, 2018
Array-based DNA-methylation profiling in sarcomas with small blue round cell histology provides valuable diagnostic informationChristian Koelsche, Wolfgang Hartmann, Daniel Schrimpf, et al.
Pageof 25

Showing results (221-230 of 248) with videos related to

Sort By:
Pageof 25
British Journal of Cancer|January 21, 2022
The association of Health-Related Quality of Life and 1-year-survival in sarcoma patients-results of a Nationwide Observational Study (PROSa)Martin Eichler, Susanne Singer, Leopold Hentschel, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2025
Conference on challenges in sarcoma (CCS) 2024: Expert opinions on non-evidence-based management aspectsSilvia Hofer, Chantal Pauli, Beata Bode, et al.
Nature Communications|August 4, 2019
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AMLThomas Oellerich, Constanze Schneider, Dominique Thomas, et al.
The American Journal of Pathology|January 26, 2021
Gene Expression in Solitary Fibrous Tumors (SFTs) Correlates with Anatomic Localization and NAB2-STAT6 Gene Fusion VariantsMatthias Bieg, Evgeny A Moskalev, Rainer Will, et al.
Genes, Chromosomes & Cancer|October 26, 2019
Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assaysNicole Pfarr, Martina Kirchner, Ulrich Lehmann, et al.
JAMA|March 29, 2012
One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trialHeikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, et al.
Frontiers in Endocrinology|September 15, 2023
Health related Quality of Life over time in German sarcoma patients. An analysis of associated factors - results of the PROSa studyMartin Eichler, Leopold Hentschel, Susanne Singer, et al.
Clinical Orthopaedics and Related Research|October 4, 2019
Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 TrialDimosthenis Andreou, Andreas Ranft, Georg Gosheger, et al.
Cancers|December 3, 2020
The Health-Related Quality of Life of Sarcoma Patients and Survivors in Germany-Cross-Sectional Results of a Nationwide Observational Study (PROSa)Martin Eichler, Leopold Hentschel, Stephan Richter, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 25, 2018
Array-based DNA-methylation profiling in sarcomas with small blue round cell histology provides valuable diagnostic informationChristian Koelsche, Wolfgang Hartmann, Daniel Schrimpf, et al.
Pageof 25